JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Validation of signature molecular profiles of advanced HCV liver disease in hepatocellular carcinoma patients

  • 0Department of Microbiology, Immunology, and Genetics, University of North Texas Health Science Center, Fort Worth, Texas, 76107, USA.
Virus Research +

|

June 9, 2025

|

June 9, 2025

View abstract on PubMed

Summary

This summary is machine-generated.

Hepatitis C virus (HCV) infection alters gene expression in liver cells, impacting liver disease progression and hepatocellular carcinoma (HCC) development. Identified genes could serve as diagnostic markers and therapeutic targets for HCV-related liver cancer.

Area Of Science

  • Hepatology and Viral Oncology
  • Molecular Biology and Genomics

Background

  • Hepatitis C virus (HCV) infection significantly alters hepatocellular gene expression in a stage-specific manner.
  • Understanding these alterations is crucial for identifying mechanisms underlying HCV-mediated hepatocellular carcinoma (HCC) development.

Purpose Of The Study

  • To identify and validate differentially expressed genes during HCV infection that correlate with liver disease progression and HCC.
  • To evaluate the potential of these genes as prognostic, diagnostic, and therapeutic targets for HCV-related liver diseases.

Main Methods

  • Transcriptome analysis to identify differentially expressed genes.
  • In silico assays including heatmap, volcano analysis, and TCGA-HCC database analysis.
  • Molecular validation using qRT-PCR and immunoblot analyses.

Main Results

  • Identified two up-regulated genes: aldo-keto reductase family 1 member B10 (AKR1B10) and hexokinase domain containing 1 (HKDC1).
  • Identified two down-regulated genes: glycine N-methyltransferase (GNMT) and C-type lectin domain family 4, member M (CLEC4M).
  • Validated differential expression of these genes across various liver disease stages.

Conclusions

  • The identified differentially expressed genes (AKR1B10, HKDC1, GNMT, CLEC4M) are significantly associated with liver disease progression in HCV infection.
  • These genes show potential as prognostic and diagnostic biomarkers for liver disease.
  • Targeting these genes may offer novel therapeutic strategies against HCV-mediated HCC.

Keywords: